Comparison of clinical and molecular characteristics of patients with acute myeloid leukemia and either TP73 or TP53 mutations.
Alice S MimsJessica KohlschmidtAnn-Kathrin EisfeldKrzysztof MrόzekJames S BlachlyShelley OrwickDimitrios PapaioannouDeedra NicoletDeepa SampathRichard M StoneBayard L PowellJonathan E KolitzJohn C ByrdClara D BloomfieldPublished in: Leukemia (2020)